Three-dimensional conformal radiotherapy for locally advanced (Stage II and worse) head-and-neck cancer: Dosimetric and clinical evaluation

International Journal of Radiation Oncology Biology Physics

Volumn 66, Issue 4, 2006, Pages 1036-1043

  Portaluri, Maurizio ^a,b   Fucilli, Fulvio I M ^a   Castagna, Roberta ^a   Bambace, Santa ^a   Pili, Giorgio ^a   Tramacere, Francesco ^a   Russo, Donatella ^a   Francavilla, Maria Carmen ^a  

^a Di Summa Hospital   (Italy)

^b CNR   (Italy)

Author keywords

3D CRT; Head and neck cancer; Xerostomia

Indexed keywords

BIOLOGICAL ORGANS; CELLS; CHEMOTHERAPY; DOSIMETRY; PATIENT TREATMENT; TUMORS;

CONTRALATERAL PAROTID GLAND; HEAD-AND-NECK CANCER; RADIATION THERAPY ONCOLOGY GROUP; XEROSTOMIA;

RADIOTHERAPY;

CISPLATIN; FLUOROURACIL;

ADULT; ADVANCED CANCER; AGED; ARTICLE; CANCER COMBINATION CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER STAGING; CLINICAL ARTICLE; COMPUTER ASSISTED RADIOTHERAPY; CONTROLLED STUDY; DOSIMETRY; FEMALE; FOLLOW UP; HEAD AND NECK CANCER; HISTOPATHOLOGY; HUMAN; LARYNX CANCER; MALE; MOUTH CANCER; NASOPHARYNX CANCER; OROPHARYNX CANCER; POSTOPERATIVE CARE; PRESCRIPTION; PRIORITY JOURNAL; RADIATION DOSE; SCORING SYSTEM; SQUAMOUS CELL CARCINOMA; XEROSTOMIA;

ADULT; AGED; AGED, 80 AND OVER; BODY BURDEN; CARCINOMA, SQUAMOUS CELL; FEMALE; HEAD AND NECK NEOPLASMS; HUMANS; MALE; MIDDLE AGED; RADIOMETRY; RADIOTHERAPY DOSAGE; RADIOTHERAPY PLANNING, COMPUTER-ASSISTED; RADIOTHERAPY, CONFORMAL; RELATIVE BIOLOGICAL EFFECTIVENESS; TREATMENT OUTCOME;

EID: 33750328878     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2006.03.014     Document Type: Article

References (24)

1. Ringash J., Warde P., Lockwood G., et al. Postradiotherapy quality of life for head-and-neck cancer patients is independent of xerostomia. Int J Radiat Oncol Biol Phys 61 (2005) 1403-1407
2. Brizel D.M., Wasserman T.H., Henke M., et al. Phase III randomized trial of amifostine as radioprotector in head and neck cancer. J Clin Oncol 18 (2000) 3339-3345
3. Cooper J.S., Fu K., Marks J., et al. Late effects of radiation therapy in the head and neck region. Int J Radiat Oncol Biol Phys 55 (2003) 312-321
4. Eisbruch A., Ten Haken R.K., Kim H.M., et al. Dose volume and function relationships in parotid salivary glands following conformal and intensity-modulated irradiation of head and neck cancer. Int J Radiat Oncol Biol Phys 45 (1999) 577-587
5. Blanco A.I., Chao K.S.C., El Naqa I., et al. Dose-volume modeling of salivary function in patients with head-and-neck cancer receiving radiotherapy. Int J Radiat Oncol Biol Phys 62 (2005) 1055-1069
6. Eisbruch A., Hyungjin M., Kim H.M., et al. Xerostomia and its predictors following parotid-sparing irradiation of head and neck cancer. Int J Radiat Oncol Biol Phys 50 (2001) 695-704
7. Saarilahti K., Kouri M., Collan J., et al. Intensity modulated radiotherapy for head and neck cancer: Evidence for preserved salivary gland function. Radiother Oncol 74 (2005) 251-258
8. Maes A., Weltens C., Flamen P., et al. Preservation of parotid function with uncomplicated conformal radiotherapy. Radiother Oncol 63 (2002) 203-211
9. Kontis T., and Johns M. Anatomy and physiology of the salivary glands. In: Bailey B., Healy G., et al. (Eds). Head and neck surgery-Otolaryngology (2001), Lippincott Williams & Wilkins, Philadelphia 1-12
10. Gregoire V., Coche E., Cosnard G., et al. Selection and delineation of lymph node target volumes in head and neck conformal radiotherapy: Proposal for standardizing terminology and procedure based on the surgical experience. Radiother Oncol 56 (2000) 135-150
11. Geets X., Daisne J.F., Arcangeli S., et al. Inter-observer variability in the delineation of pharyngo-laryngeal tumor, parotid glands and cervical spinal cord: Comparison between CT scan and MRI. Radiother Oncol 77 (2005) 1-7
12. Cozzi L., Fogliata R.A., Lomax A.R., et al. A treatment planning comparison of 3D conformal therapy, intensity modulated photon therapy and proton therapy for treatment of advanced head and neck tumours. Radiother Oncol 61 (2001) 287-297
13. Fogliata A., Bolsi A., and Cozzi L. Comparative analysis of intensity modulation inverse planning modules of three commercial treatment planning systems applied to head and neck tumour model. Radiother Oncol 66 (2003) 29-40
14. Cozzi L., Fogliata A., Bolsi A., et al. Three dimensional conformal vs. intensity modulated radiotherapy in H&N cancer patients: Comparative analysis of dosimetric and technical parameters. Int J Radiat Oncol Biol Phys 58 (2004) 617-624
15. Wu Q., Manning M., Schmidt-Ulrich R., et al. The potential for sparing of parotids and escalation of biologically effective dose with intensity modulated radiation treatments of head and neck cancers: A treatment design study. Int J Radiat Oncol Biol Phys 46 (2000) 195-205
16. Fogliata A., Cozzi L., Bieri S., et al. Critical appraisal of a conformal head and neck cancer irradiation avoiding electron beams and field matching. Int J Radiat Oncol Biol Phys 45 (1999) 1331-1338
17. Eisbruch A., Ship J.A., Martel M.K., et al. Parotid gland sparing in patients undergoing bilateral head-and-neck irradiation: Technique and early results. Int J Radiat Oncol Biol Phys 36 (1996) 469-480
18. Bussel B., Annelies M., Flamen P., et al. Dose-response relationship within the parotid gland after radiotherapy for head and neck cancer. Radiother Oncol 73 (2004) 297-306
19. Braaksma M.M.J., Wijers O.B., van Sorsen de Koste J.R., et al. Optimisation of conformal radiation therapy by intensity modulation: Cancer of the larynx and salivary gland function. Radiother Oncol 66 (2003) 291-302
20. Chao C.K.S., Deasy J.O., Markman J., et al. A prospective study of salivary function sparing in patients with head and neck cancer receiving intensity modulated or three dimensional radiation therapy: Initial results. Int J Radiat Oncol Biol Phys 49 (2001) 907-916
21. Martel M.K., Eisbruch A., Lawrence T.S., et al. Spinal cord dose from standard head and neck irradiation: Implications for three-dimensional treatment planning. Radiother Oncol 47 (1997) 185-189
22. Fox P.C., Busch K.A., and Baum B.J. Subjective reports of xerostomia and objective measures of salivary gland performance. J Am Dent Assoc 115 (1987) 581-584
23. Blanco A.I., Chao C.K.S., El Naqua I., et al. Dose-volume modeling of salivary function in patients with head-and-neck cancer receiving radiotherapy. Int J Radiat Oncol Biol Phys 62 (2005) 1055-1069
24. Amosson C.M., Teh B.S., El Naqua I., et al. Dosimetric predictors of xerostomia for head-and-neck cancer patients treated with the smart (simultaneous modulated accelerated radiation therapy) boost technique. Int J Radiat Oncol Biol Phys 56 (2003) 136-144